-
Guangzhou Health Center has made progress in the research of antibody immune response in the new coronavirus escaping population
Time of Update: 2023-01-06
The study found a human neutralizing antibody R1-32 that targets the viral protein receptor binding domain (RBD) semi-hidden epitope and has a high affinity, mainly Prevents the virus from entering the cell by breaking open the spike protein and disintegrating it; Analysis of the antibody panel library showed that R1-32-like antibodies encoded by IGHV1-69 were widely induced in people infected with the new crown.
-
Guangzhou Health Center has made progress in the research of antibody immune response in the new coronavirus escaping population
Time of Update: 2023-01-06
The study found a human neutralizing antibody R1-32 that targets the viral protein receptor binding domain (RBD) semi-hidden epitope and has a high affinity, mainly Prevents the virus from entering the cell by breaking open the spike protein and disintegrating it; Analysis of the antibody panel library showed that R1-32-like antibodies encoded by IGHV1-69 were widely induced in people infected with the new crown.
-
"Parkinson's disease drugs" cross-border "type 1 diabetes" treatment? Bromocriptine has shown therapeutic potential to improve blood pressure and aortic stiffness
Time of Update: 2023-01-01
In this study, investigators assessed the effects of bromocriptine on blood pressure and aortic sclerosis in adolescents with type 1 diabetes compared with placebo.
In this study, investigators assessed the effects of bromocriptine on blood pressure and aortic sclerosis in adolescents with type 1 diabetes compared with placebo.
-
The European Court of Justice formally annuls the decision to classify the carcinogenicity of titanium dioxide
Time of Update: 2023-01-01
Recently, the European General Court of Justice annulled the European Commission's decision on the classification of titanium dioxide carcinogenicity.
Recently, the European General Court of Justice annulled the European Commission's decision on the classification of titanium dioxide carcinogenicity.
-
National Health Commission: is guiding all localities to accelerate the construction of fever clinics
Time of Update: 2022-12-30
Nie Chunlei, director of the Department of Primary Health of the National Health Commission, said in Beijing on the 15th that he is guiding all localities to accelerate the construction of fever clinics (outpatient clinics), and accelerate the installation rate of fever clinics (outpatient clinics) by renovating and expanding fever sentinel points and purchasing prefabricated panel rooms.
-
Chinese scholars have made progress in the study of soil in situ active antibiotic-resistant bacteria tracing and drug resistance transmission
Time of Update: 2022-10-13
Single-cell Raman technology assesses soil phenotypic resistance and targets sorting and sequencing of highly active drug-resistant bacteria With the support of the National Natural Science Foundatio
-
2021 Fifth Edition Update Highlights of the NCCN Bladder Cancer Guidelines
Time of Update: 2022-04-29
◆Adjuvant nivolumab Consider use in ypT2-ypT4a or ypN+ patients who have received prior neoadjuvant chemotherapy Consider adjuvant RT with nivolumab in T3-T4, node-positive, or border-positive patients (category 2B recommendation) Footnote added: Best suited for patients who value delayed chance of recurrence and consider the risk of adverse effects to be acceptable, and accept complete disease remission The chances of patients not improving .
-
JNIR: Portal for chronically ill patients during the COVID-19 pandemic: A review of functional characteristics and theoretical framework of a telerehabilitation platform
Time of Update: 2022-04-18
Web Portals for Patients With Chronic Diseases: Scoping Review of the Functional Features and Theoretical Frameworks of Telerehabilitation Platforms.
J Med Internet Res 2022 01 27;24(1) Web Portals for Patients With Chronic Diseases: Scoping Review of the Functional Features and Theoretical Frameworks of Telerehabilitation Platforms.
-
Evonik joins hands with partners to launch joint product search service for coating formulations
Time of Update: 2022-04-16
• Accelerated expansion of coating formulation network: cooperation with raw material suppliers LANXESS and Centrema • Faster targeting: efficient search for additives, binders and pigments • Search for raw materials according to regulatory requirements and technical specifications Evonik, together with Lanxess and Xintema, launched a joint search service for professional product information for the coatings industry, aiming to help improve the transparency of the coatings market, reduce the workload of formulators, and create an industry-level cooperation network .
-
Data on Omicron infection cases in the United States, and expert thinking
Time of Update: 2022-01-08
S. Centers for Disease Control and Prevention reported on Tuesday that 95% of the new coronavirus infections in the United States last week were caused by Omicron, which once again shows how fast the mutated virus has spread since the mutated virus was first detected in South Africa at the end of November.
-
New coronavirus research becomes the biggest winner, CRISPR-like enzymes and the gold standard for masks
Time of Update: 2021-10-01
The authors of the study found that in the villages where the research team distributes masks and promotes their use, surgical masks—rather than cloth masks—reduce the spread of SARS-CoV-2 ( https://go.
-
Henan Baililian's annual production of 100,000 tons of chloride titanium dioxide expansion project environmental impact assessment public participation in the second information
Time of Update: 2021-07-20
2. Construction unit name and contact information Unit name: Henan Baililian New Materials Co.
The public can obtain the project report solicitation draft and public comment form through or contact the construction unit to the factory of Henan Baililian New Materials Co.
-
Merck's Keytruda treatment of urothelial cancer was rejected by NICE in the UK
Time of Update: 2021-07-16
On March 18, the National Institute of Health and Care Excellence (NICE) issued the second final assessment document, rejecting Merck’s Keytruda for the treatment of advanced bladder cancer .
-
Anqing Petrochemical Railway Dedicated Railway Operated for 9,200 Days of Continuous and Safe Operation
Time of Update: 2021-06-04
The Transportation Department of Anqing Petrochemical always adheres to safety as a trivial matter and carefully builds safe railway lines.
The Anqing Petrochemical Transportation Department "strengthens to ensure safety" allows management to escort safe production and assessment to escort production.
-
The Lancet: herd immunity and vaccines to prevent infection
Time of Update: 2021-05-07
Infection immunity COVID-19In The Lancet , Victoria J Hall and colleagues7 reported the effectiveness of BNT162b2 against SARS-CoV-2 infection through an observational SIREN (SARS-CoV-2 Immunization and Reinfection Assessment) study.
